Inpart — Life Sciences R&D Partnering and Innovation Platform
End-to-end platform for R&D partnerships
Inpart provides a specialized platform for R&D partnerships within the life sciences sector. The company helps organizations discover, manage, and deliver high-impact innovation more efficiently. Its main offering unifies data, insights, and teams into a single, cohesive system.Inpart supports the complete Partner Lifecycle Management journey, from initial partner discovery and evaluation to long-term alliance management. This approach creates a single source of truth. It empowers teams to make faster, more informed decisions and accelerates scientific breakthroughs through effective collaboration.
Inpart is a specialized technology company that provides an end-to-end platform for R&D partnerships. It helps life science organizations discover, manage, and deliver innovation faster by unifying data, insights, and teams. The company’s flagship platform provides a single source of truth for the entire partnering lifecycle. Key differentiators include a powerful data harmonization engine, a global network of scientific partners. And enterprise-grade security for sensitive R&D data.
"Inpart has enabled Lilly to standardize processes, enable more consistent data across the entire External Innovation community and place data more directly into the hands of business development leadership."
— External Innovation Operations Director, Eli Lilly
Value Proposition & Business Summary
Inpart is a technology company delivering an end-to-end platform for R&D partnerships in the life sciences sector. The company's primary mission is to accelerate innovation by unifying data, insights, and teams into a single, cohesive system. Inpart's unique selling proposition lies in its ability to manage the complete Partner Lifecycle Management journey, from initial partner discovery to long-term alliance management. This creates a single source of truth that breaks down departmental silos and eliminates data fragmentation. The platform is trusted by over 500 clients, including a majority of the world's top pharmaceutical and biotech companies. Core features include a powerful data harmonization engine that turns complex information into actionable intelligence, access to a global network of scientific partners, and enterprise-grade security. By streamlining workflows and enabling faster, data-driven decisions, Inpart helps organizations reduce costs, save time, and increase the value of their innovation portfolios.
Quick Facts
Core Competencies & Key Features
Partner Discovery & Sourcing
Identify and find new partners and opportunities through a global network of companies and academic institutions.
Deal Sourcing & Evaluation
Streamline deal sourcing, evaluation, and prioritization with structured, reliable data in a single connected system.
Alliance Management
Track partnership obligations, performance, and key outcomes to maximize the long-term value of strategic alliances.
Data Harmonization
Transform unstructured and fragmented R&D data into standardized, comparable insights that power faster, smarter decisions.
Open Innovation Management
Launch external innovation challenges, engage with innovators, and capture all submissions within one centralized system.
R&D Collaboration
Unite cross-functional stakeholders across departments and borders to move strategic research partnerships forward collaboratively.
Awards & Certifications
Major Partners & Clients
Key Takeaways
Products & Services
The core of the Inpart platform is its ability to create a single source of truth. This ensures all stakeholders work from the same reliable information. The platform connects workflows seamlessly.
It enables collaboration from initial scouting and evaluation to dealmaking and long-term alliance management. Its services is designed to turn complex scientific data into clear, actionable intelligence.
Partner Discovery and Network Access
This core capability focuses on helping organizations find the right partners and opportunities more quickly. Inpart provides access to a vast and active global network to accelerate external innovation and sourcing efforts.
Inpart Connect
This service allows companies to uncover new partners and promising opportunities. It taps into a global network of over 4,000 biotech companies. It also includes more than 2,600 universities and academic institutes. The network contains over 20,000 active members, providing a rich source for scientific landscaping and partner identification.
Centralized Partner and Deal Management
Inpart offers a secure system built for modern dealmaking and collaboration. It unifies scattered information and complex workflows into one cohesive environment, supporting all stages of Partner Ecosystem Management.
Inpart Deal
This product acts as a central command center for partnerships. It allows teams to bring every partnership, team member, and insight together in one place. The system securely manages cross-functional workflows. It simplifies deal sourcing, negotiations, and due diligence. All information is organized and easily accessible to authorized users.
Data Intelligence and Harmonization
This service addresses the critical challenge of fragmented and unstructured data. Inpart’s technology transforms complex information into a standardized, comparable, and actionable format for better decision-making.
Data Engine
At the core of the platform is a powerful data harmonization engine. It ingests unstructured information from various sources. The engine then standardizes taxonomies and data points. This process creates comparable insights that power smarter and faster evaluations. The resulting data is clean, reliable, and AI-ready for future applications.
Frequently Asked Questions
Inpart provides a unified platform for life science companies to manage R&D partnerships. It helps teams discover new opportunities, evaluate potential partners, and manage alliances. The platform unifies data and workflows to create a single source of truth.
This accelerates innovation by making collaboration faster and more efficient.
The Inpart platform uss by over 500 organizations in the life sciences industries. This includes 70% of the top 50 global pharmaceutical companies. It also serves 24 of the 25 leading biotech and pharma R&D firms.
The system builts for any company focused on external innovation.
Inpart helps companies discover partners through its Inpart Connect service. This provides access to a global network of over 4,000 biotech companies and 2,600 universities.This large, active network allows teams to run targeted searches. And landscaping projects to find the best scientific partners and opportunities.
Inpart's data harmonization engine turns complex, unstructured R&D data into standardized, actionable insights. This allows teams to compare different opportunities more easily and make evaluation decisions up to three times faster. It creates a reliable, AI-ready foundation for all partnering intelligence and removes data fragmentation.
Inpart helps alliance managers track obligations, performance, and outcomes for their partnerships. The platform provides a centralized space to monitor goals, key decisions, and next steps.This ensures the full history and context of an alliance is. Captured in one place, helping to maximize its long-term value.
Yes, the Inpart platform builts with enterprise-grade security. It is ISO 27001 certified, which is a leading international standard for information security management. It is also fully GDPR compliant.
These measures ensure that all client data, including sensitive R&D information, is always protected and handled correctly.